132 related articles for article (PubMed ID: 28525495)
21. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
22. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
[TBL] [Abstract][Full Text] [Related]
23. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
[TBL] [Abstract][Full Text] [Related]
24. Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate-Risk Stage I Endometrial Cancer.
McGunigal M; Pollock A; Doucette JT; Liu J; Chadha M; Kalir T; Gupta V
Int J Gynecol Cancer; 2018 Jun; 28(5):882-889. PubMed ID: 29538253
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.
Nasioudis D; Byrne M; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
Gynecol Oncol; 2021 Jun; 161(3):705-709. PubMed ID: 33771397
[TBL] [Abstract][Full Text] [Related]
26. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
Samayoa AX; Pezzi TA; Pezzi CM; Greer Gay E; Asai M; Kulkarni N; Carp N; Chun SG; Putnam JB
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1005-1011. PubMed ID: 27531307
[TBL] [Abstract][Full Text] [Related]
27. Radiation and hormonal therapy for primary treatment of stage I endometrial cancer and long-term survival.
Pyrzak A; Chen L; Kocherginsky M; Barber EL
Gynecol Oncol; 2020 Aug; 158(2):331-338. PubMed ID: 32553589
[TBL] [Abstract][Full Text] [Related]
28. Trends in Treatment of Uterine Serous Cancer in the Medicare Population.
Rauh-Hain JA; Connor SC; Clemmer JT; Foley OW; Clark RM; Hall TR; Boruta DM; Schorge JO; del Carmen MG
Int J Gynecol Cancer; 2015 Jul; 25(6):1023-30. PubMed ID: 25914960
[TBL] [Abstract][Full Text] [Related]
29. Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer.
Cox Bauer CM; Greer DM; Kram JJF; Kamelle SA
Gynecol Oncol; 2016 May; 141(2):199-205. PubMed ID: 26905210
[TBL] [Abstract][Full Text] [Related]
30. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
[TBL] [Abstract][Full Text] [Related]
32. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
[TBL] [Abstract][Full Text] [Related]
33. Impact of lymphadenectomy in uterine endometrioid carcinoma.
Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF
Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243
[TBL] [Abstract][Full Text] [Related]
34. What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis.
Modh A; Ghanem AI; Burmeister C; Hanna RK; Elshaikh MA
Int J Gynecol Cancer; 2018 Feb; 28(2):248-253. PubMed ID: 29240603
[TBL] [Abstract][Full Text] [Related]
35. Role of systematic lymphadenectomy and adjuvant radiation in early-stage endometrioid uterine cancer.
Jeong NH; Lee JM; Lee JK; Kim MK; Kim YJ; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Ann Surg Oncol; 2010 Nov; 17(11):2951-7. PubMed ID: 20556522
[TBL] [Abstract][Full Text] [Related]
36. Improved Outcome of High-Grade, Early 1-Stage Endometrioid Endometrial Carcinoma With Adjuvant Chemotherapy and Radiotherapy: Comparison of 2 Treatment Strategies.
Reynaers EA; Jutzi L; Ezendam NP; Kwon JS; Pijnenborg JM
Int J Gynecol Cancer; 2017 Mar; 27(3):467-472. PubMed ID: 28129237
[TBL] [Abstract][Full Text] [Related]
37. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
[TBL] [Abstract][Full Text] [Related]
38. Should all endometrioid uterine cancer patients undergo systemic lymphadenectomy?
Wang ZQ; Wang JL; Shen DH; Li XP; Wei LH
Eur J Surg Oncol; 2013 Apr; 39(4):344-9. PubMed ID: 23333067
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium.
Nasioudis D; Roy AG; Ko EM; Cory L; Giuntoli Ii RL; Haggerty AF; Kim SH; Morgan MA; Latif NA
Int J Gynecol Cancer; 2020 Aug; 30(8):1089-1094. PubMed ID: 32675056
[TBL] [Abstract][Full Text] [Related]
40. Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.
Mahdi H; Munkarah AR; Ali-Fehmi R; Woessner J; Shah SN; Moslemi-Kebria M
Arch Gynecol Obstet; 2015 Jul; 292(1):183-90. PubMed ID: 25549769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
